STC314

CAS No. 186295-19-2

STC314( —— )

Catalog No. M36601 CAS No. 186295-19-2

STC314 is an anti-infective agent that reverses organ damage caused by excessive immune response by neutralizing extracellular histones and neutrophil trapping networks, and can be used in the study of sepsis and acute respiratory distress syndrome (ARDS).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 2125 Get Quote
5MG 2831 Get Quote
25MG 7176 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    STC314
  • Note
    Research use only, not for human use.
  • Brief Description
    STC314 is an anti-infective agent that reverses organ damage caused by excessive immune response by neutralizing extracellular histones and neutrophil trapping networks, and can be used in the study of sepsis and acute respiratory distress syndrome (ARDS).
  • Description
    STC314 is a small polyanion that interact electrostatically with histones. STC314 blocks disruption of lipid-bilayers by histones that inhibits the cytotoxic, platelet-activating and erythrocyte-damaging effects of histones. STC314 has anti-infective effects and can be uesd for sepsis research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186295-19-2
  • Formula Weight
    1070.64
  • Molecular Formula
    C13H17Na7O32S7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(O[C@H]([C@H]([C@@H](O[C@@H]1COS(=O)([O-])=O)OC)OS(=O)([O-])=O)[C@@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)COS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)OS(=O)([O-])=O)([O-])=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Connor H O' Meara, et al. Neutralizing the pathological effects of extracellular histones with small polyanions. Nat Commun. 2020 Dec 16;11(1):6408. ?
molnova catalog
related products
  • Frovocimab

    Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.

  • APOBEC3G-IN-1

    APOBEC3G-IN-1 (MN136.0185) is a targeted inhibitor of APOBEC3G with anti-HIV activity, used for researching infectious diseases and cancer.

  • Pomalidomide-PEG3-OH

    Pomalidomide-PEG3-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.